ÂÜÀòÂÒÂ×

Lucy joined eXmoor after eight years at the Centre for Process Innovation (CPI) with her final position as Director of Biologics and COVID response.

She recently led the establishment of the UK’s RNA Centre of excellence in response to the COVID-19 pandemic as a member of the UK Vaccines Taskforce.

In 2013, as the Lead Biopharmaceutical Engineer at CPI, Lucy collaborated with eXmoor on the concept design of the organisation’s Darlington-based National Biologics Manufacturing

Centre.

Previously, she was an academic at Newcastle University in both the Business School and Chemical Engineering Departments where she worked with Professors Lyddiatt and Whitaker to understand the route to widespread adoption and process industrialisation of advanced therapies.